Novartis picks up FDA approval for targeted lung cancer meds Tafinlar, Mekinist
admin 23rd June 2017 Uncategorised 0Patients in the U.S. with a specific lung cancer will soon have their first targeted treatment with Novartis’ FDA approval for Tafinlar plus Mekinist.
More: Novartis picks up FDA approval for targeted lung cancer meds Tafinlar, Mekinist
Source: fierce